Immuneel Raises ₹100 Cr for Global Gene Therapy Push

Immuneel Therapeutics raised ₹100 Cr in Series B funding from Singularity AMC and Rainmatter by Zerodha. The biotech startup will use the capital to scale GMP manufacturing, advance its cell and gene therapy pipeline, and expand into Asia-Pacific and the Middle East. The company offers CAR-T cell therapy for blood cancer in India.